U.S. market Closed. Opens in 17 hours 16 minutes

VRPX | Virpax Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.2600 - 1.5000
52 Week Range 0.4603 - 9.77
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 540,170
Average Volume 5,216,555
Shares Outstanding 4,813,181
Market Cap 6,160,872
Sector Healthcare
Industry Biotechnology
IPO Date 2021-02-17
Valuation
Profitability
Growth
Health
P/E Ratio -0.09
Forward P/E Ratio N/A
EPS -14.42
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 7
Country USA
Website VRPX
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
*Chart delayed
Analyzing fundamentals for VRPX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see VRPX Fundamentals page.

Watching at VRPX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on VRPX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙